Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.470
-0.030 (-2.00%)
At close: Jul 11, 2025, 4:00 PM
1.450
-0.020 (-1.36%)
After-hours: Jul 11, 2025, 7:58 PM EDT
PACB Employees
Pacific Biosciences of California had 575 employees as of December 31, 2024. The number of employees decreased by 221 or -27.76% compared to the previous year.
Employees
575
Change (1Y)
-221
Growth (1Y)
-27.76%
Revenue / Employee
$264,969
Profits / Employee
-$1,143,910
Market Cap
441.12M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PACB News
- 5 weeks ago - Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date - PRNewsWire
- 2 months ago - PacBio Board Independent Investigation Concludes Allegations Unsubstantiated - GlobeNewsWire
- 2 months ago - Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - PacBio Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand - GlobeNewsWire
- 2 months ago - PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry - GlobeNewsWire
- 2 months ago - Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa - GlobeNewsWire
- 3 months ago - PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million - GlobeNewsWire